Leiva-Torres GA - Search Results

1

Weak and partial D phenotyping: a comparison study between molecular and serologic results.

Theiler C, Lomas-Francis C, Vege S, Chevrier MC, Leiva-Torres GA, Keller MA, Kaherl K, Coppolino T, Johnson ST. Theiler C, et al. Among authors: leiva torres ga. Immunohematology. 2024 Dec 31;40(4):159-165. doi: 10.2478/immunohematology-2024-022. Print 2024 Dec 1. Immunohematology. 2024. PMID: 39740012

2

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors.

Lemieux W, Perreault J, Leiva-Torres GA, Baillargeon N, Yanez JC, Chevrier MC, Richard L, Lewin A, Trépanier P. Lemieux W, et al. Among authors: leiva torres ga. Future Virol. 2023 Jan:10.2217/fvl-2022-0058. doi: 10.2217/fvl-2022-0058. Epub 2023 Feb 20. Future Virol. 2023. PMID: 36844192 Free PMC article.

3

Planning antepartum directed donations in preparation for neonatal cardiac surgery in the absence of compatible donors.

Bienz M, Constanzo-Yanez J, Baillargeon N, Leiva-Torres GA, Boileau M, Cloutier M, Laforce-Lavoie A, Robitaille N. Bienz M, et al. Among authors: leiva torres ga. Transfusion. 2024 Dec 2. doi: 10.1111/trf.18087. Online ahead of print. Transfusion. 2024. PMID: 39623742

4

Are D+ units safe for D+ patients with anti-D?

Robitaille N, Leiva-Torres GA. Robitaille N, et al. Among authors: leiva torres ga. Blood. 2024 Nov 7;144(19):1982-1983. doi: 10.1182/blood.2024026567. Blood. 2024. PMID: 39509124 No abstract available.

5

Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.

Leiva-Torres GA, Cigna M, Constanzo-Yanez J, St-Louis M, Perreault J, Lavoie J, Laflamme G, Lewin A, Pastore Y, Robitaille N. Leiva-Torres GA, et al. Transfusion. 2024 Apr;64(4):716-726. doi: 10.1111/trf.17778. Epub 2024 Mar 18. Transfusion. 2024. PMID: 38497419

6

Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation.

Cigna M, Leiva-Torres GA, Baillargeon N, Yanez JC, Robitaille N. Cigna M, et al. Among authors: leiva torres ga. Transfusion. 2024 Mar;64(3):554-559. doi: 10.1111/trf.17715. Epub 2024 Jan 11. Transfusion. 2024. PMID: 38205646

7

Incidence of acute haemolytic transfusion reaction among ABO-incompatible recipients transfused with A₃ blood: A case series.

Latour C, Gaussen A, Beaudoin J, Leiva-Torres GA, Rochette S, Robitaille N. Latour C, et al. Among authors: leiva torres ga. Vox Sang. 2023 Oct;118(10):854-862. doi: 10.1111/vox.13503. Epub 2023 Aug 17. Vox Sang. 2023. PMID: 37589206

8

Weak D type 42: Antigen density and risk of alloimmunization in the province of Québec.

Morin PA, Perreault J, St-Louis M, Leiva-Torres GA, Robitaille N, Trépanier P. Morin PA, et al. Among authors: leiva torres ga. Vox Sang. 2022 Jul;117(7):943-948. doi: 10.1111/vox.13271. Epub 2022 Mar 17. Vox Sang. 2022. PMID: 35297064

9

A novel KEL null allele with c.223+1g>t leads to the absence of the Kp^b antigen in a First Nation donor.

Leiva-Torres GA, Lavoie J, Ethier C, Constanzo-Yanez J, Baillargeon N. Leiva-Torres GA, et al. Transfusion. 2021 Sep;61(9):E65-E66. doi: 10.1111/trf.16604. Epub 2021 Jul 26. Transfusion. 2021. PMID: 34310722 No abstract available.

10

High prevalence of weak D type 42 in a large-scale RHD genotyping program in the province of Quebec (Canada).

Leiva-Torres GA, Chevrier MC, Constanzo-Yanez J, Lewin A, Lavoie J, Laganière J, Baillargeon N, Trépanier P, Robitaille N. Leiva-Torres GA, et al. Transfusion. 2021 Sep;61(9):2727-2735. doi: 10.1111/trf.16518. Epub 2021 Jun 14. Transfusion. 2021. PMID: 34121202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters